- This topic is empty.
-
Posts
-
-
Cramer’s week ahead: We’re fighting a ‘two-front war’ with coronavirus (https://www.cnbc.com/2020/03/20/cramer-week-ahead-were-fighting-a-two-front-war-with-coronavirus.html)
- The United States is facing a “two-front war” with the coronavirus outbreak and a looming global economic crisis, which is compounded by the state of the oil market, the “Mad Money” host said.
- “We know this market is the most oversold it’s ever been. We know that if there’s any good news — a clinical trial success, more testing, a cresting of new cases in Italy or Spain, a $3 trillion stimulus bill, or oil back, let’s say, at $26 — the averages would roar,” Cramer said. “But, somehow, all those positives, they seem to have become long shots.”
Ticker: NKE, PAYX, MU, SIG, LULU
Executive Interview: Crowdstrike reports a ‘real uptick in phishing campaigns’ during coronavirus crisis (https://www.cnbc.com/2020/03/20/crowdstrike-sees-phishing-attack-uptick-during-coronavirus-crisis.html)
- “We’ve seen a real uptick in phishing campaigns using COVID-19 and malware associated with that in these emails,” Crowdstrike CEO George Kurtz told CNBC.
- “When there’s chaos and there’s this fear in the street that’s when the adversary tends to strike hardest,” he said in a “Mad Money” interview.
- “As these remote users get up and running with their own stacks, whether it’s Zoom or Slack, they’re going to need protection like Crowdstrike, and we’re there for them,” he said.
Ticker: CRWD
Executive Interview: AMN Healthcare recent acquisitions come just in time to fight coronavirus outbreak (https://www.cnbc.com/2020/03/20/amn-healthcare-new-acquisitions-to-help-hospitals-fight-virus-outbreak.html)
- AMN Healthcare’s recent acquisitions of Stratus Video and b4health are being applied to help fight the coronavirus epidemic.
- “We quickly pivoted and added capabilities so that our clients could use that platform for COVID-19 triage purposes,” CEO Susan Salka said about Stratus Video.
- “We’re working with various state associations right now to try to equip them with that technology so that they can more easily move around the very precious workforce that we have,” she said about B4health.
Ticker: AMN
Nextdoor CEO explains how communities are making use of the network during coronavirus lockdown (https://www.cnbc.com/video/2020/03/20/nextdoor-ceo-proximity-means-everything-right-now.html)
Nextdoor CEO Sarah Friar discusses collaborating with government entities, businesses and communities to exchange hyper-local info on the social service during the coronavirus shutdown.
Cramer’s lightning round: I would start a position in Abbott Labs (https://www.cnbc.com/2020/03/20/cramer-lightning-round-i-would-start-a-position-in-abbott-labs.html)
- Annaly Capital Management: “One of the reasons I have not liked Annaly is because I don’t really know what they own to be able to tell you what the dividend is saying. … I’ve been against it for ages.”
- Constellation Brands: “I keep thinking when will it bottom, but I also know that Constellation is, as you said, it’s very heavy, it’s a great seller of ours. You lose such a huge percentage of your business, it’s very hard to find a bottom. If you buy it at 3% yield, it’s at 2.5%, maybe that’s a good level to start buying. It’s a different kind of time.”
- Rockwell Automation: “They are incredibly well managed. … Maybe you buy some and then you wait down another 10%.”
- Del Taco: “It happens to be a really good company, but that’s not mattering” for the stock.
- Co-Diagnostics Inc.: “This is a COVID-19 lottery ticket. I’m not going to call it more than that. … I’d rather be in something more substantial.”
- Abbott Laboratories: “Abbot Labs was down $6 today. … If you had to start buying a position of all the stocks I’ve heard today it would be Abbott Labs, ABT.”
Ticker: NLY, STZ, ROK, TACO, CODX, ABT
If you have any questions or comments on this topic, please start a new topic using its parent forum “Investments in the US”.
-
- The topic ‘Mad Money: Key points from March 20, 2020 (Friday) episode’ is closed to new replies.